• Commercializing proprietary BioSilo® algae cultivation system
• Developing therapies that combine omega-3s and cannabinoids
• Poised to enter billion dollar markets

If you think you haven’t had cannabinoids because you’ve never used cannabis, you are completely mistaken. You may not have ‘touched’ plant-derived cannabinoids (phytocannabinoids), but it would have been biologically impossible to escape the ones produced by your body (endocannabinoids). Endocannabinoids play an essential mediating role in a number of human physiologic systems. They promote a Goldilocks internal environment, a mean between excess and deficiency in a variety of functions and areas, and recent scholarship has shown that their production is enhanced and fostered by fatty acids, the kind used by Algae Dynamics Corp. (OTCQB: ADYNF). As a result, ADYNF has begun to develop fortified formulas of omega-3s and cannabis oil that may boost the functioning of the human endocannabinoid system.

Discovery of what is now known as the endocannabinoid system has a peculiar history. It is perhaps the only known human physiologic system that is named after a plant, and that’s all because of chronology. A number of substances isolated from the cannabis plant were later found to be produced by the human body. First identification and isolation of the two major cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), is attributed to Raphael Mechoulam and his colleague Y. Gaoni in Israel in 1964. Mechoulam, whose discovery and further research into cannabis has earned him the moniker, ‘Father of Cannabis’, was also part of a team that, in 1992, discovered the endocannabinoid system.

This physiologic system plays a vital role in maintaining human health. Endocannabinoids and their receptors permeate the human body. They can be found in the brain, in various organs, in connective tissue, in glands and in immune cells. Their main function appears to be stabilizing our internal environment, freeing it from the dangerous volatility of the external world. Currently, the two best understood endocannabinoids are anandamide and 2-arachidonoylglycerol (2-AG), studies of which have uncovered a number of medical benefits they may have. Anandamide, for example, inhibits the proliferation of breast cancer cells and appears to retard the memory decline associated with Alzheimer’s disease. These encouraging findings suggest that phytocannabinoids offer a ‘natural’ way to treat a variety of ailments, including multiple sclerosis (MS), arthritis, hypertension, memory loss, pediatric epilepsy and neuropathic pain.

Research into cannabis and development of therapeutic products goes on. In Canada, as legalization looms, industry professionals are divided on whether there should be a legal distinction between medical and recreational cannabis. A recent article on CBC News Health reports comments by two researchers, who believe that medicinal and recreational cannabis should be separate (http://dtn.fm/aX2Di). They argue that a dual-stream approach would decrease the stigma associated with cannabis use for medicinal purposes, since, for example, it would be sold at a pharmacy rather than a general retailer. Dual-stream would also protect ‘the supply of strains of medical cannabis that have desirable effects for patients, such as lower THC strains sometimes used to treat children who suffer from seizures’ and also increase clinical research into the therapeutic benefits of cannabis.

The products under development by Algae Dynamics promise to pack a powerful therapeutic punch, combining the virtues of omega-3s and cannabinoids. Algae Dynamics’ algae oil is high in omega-3s DHA/DPA, which is in demand by the growing multi-billion dollar food and beverage and health care sectors. The North American omega-3 market was estimated to be $4.0 billion in 2013 and is expected to reach $5.9 billion by 2019, growing at a CAGR of 6.5% from 2014 to 2019. Supplements are the largest application segment driving North America’s omega-3 market, and the cannabinoid market is just as vibrant. It is expected to cross $2 billion in consumer sales by 2020. It seems no matter which market Algae Dynamics chooses for its products, success is almost guaranteed.

For more information, visit the company’s website at www.AlgaeDynamics.com

Let us hear your thoughts: Algae Dynamics Corp. Message Board

• IPSOS Survey for ING documents cashless payment trend growing worldwide as 78% of consumers who used cash less prior say they expect to use even less cash in the future
• North American Transaction Group, digital payment processor, drives Net Element’s revenues
• Zack’s Research projects Net Element will reach $74.6 million in revenue by 2018

Net Element, Inc. (NASDAQ: NETE) stands to benefit from a near cashless society as its North American Unified Payments group processes digital payments and drives sales for the company. A 2017 IPSOS survey for ING found that 54% of 12,585 respondents surveyed do not use cash in a restaurant. Instead, they pay by non-cash methods.

Net Element is a high technology financial group which digitally processes transactions in what is becoming a cashless society. It processes payments from both mobile devices and point-of-sale terminals. Leading the company is the North American Transaction Group. A Zack’s Research Report (http://dtn.fm/9Uwp1) projects that the company’s revenues will reach $63 million in 2017 and $74.6 million in 2018, respectively. Net Element’s North American Transaction Group generated 78% of total Net Element sales in 2016 and jumped 40% in 1Q2017.

The fifth annual ING International Survey of Mobile Banking, published in April 2017 on ING’s website eZonomics (http://dtn.fm/Ag8W1), found that 78% of those surveyed say they expect to keep using less and less cash in the future, and, good news for Net Element, only 34% of U.S. consumers say they generally carry cash. Another 38% of Americans surveyed by IPSOS would prefer to go completely cashless. A key factor in this trend is convenience, the survey said.

While 75% of U.S. consumers said they will never go completely cashless, the amount of purchases has a direct impact on whether global diners use cash or not. For instance, only 25% pay non-cash for a lunch/coffee/snack — yet, 54% go non-cash in a pricier restaurant setting.

“This year’s results tally with our mobile banking surveys in 2016, 2015 and 2014 which also found people are reducing reliance on physical cash. Increasingly they’re transacting via non-cash methods, including mobile payment apps. In fact a fraction of the population appears to have largely dispensed with cash,” the survey said. It added that many have indicated they are comfortable with new ways of paying.

The Zack’s Micro-Cap report said, “Net Element is a growth company in the payment industry that should benefit from the adoption of mobile and online payments in the US, Russia and the Middle East and ultimately globally.”

For more information, visit the company’s website at www.NetElement.com

• Fracking now accounts for half of oil production, and 90 percent of new wells are fracked
• Water remains a limited resource, yet is vital to fracking process
• American Energy Partners’ vertically-integrated subsidiaries deliver solutions

No matter what the future may hold, for now, the world runs on oil. Oil is the life blood of the world’s economic development, and obtaining oil has been an ongoing quest since long before the invention of the internal combustion engine. The first successful oil well in the U.S. was drilled near Titusville, Pennsylvania, in 1859. From there, drilling moved rapidly across the entire country, and an oil boom ensued. U.S. crude oil production peaked in 1970 at 9.64 million barrels daily, but production waned after that until the advent of advanced horizontal drilling techniques and hydraulic fracking.

Hydraulic fracking is a sophisticated drilling technology that has exponentially expanded petroleum and natural gas production in the United States. Fracking now accounts for over half of U.S. oil production and two-thirds of natural gas production in the country, making the U.S. the largest natural gas producer in the world. However, large use of water in the fracking process creates controversy. Water is vital to the hydraulic fracking process, and competition for water is fierce.

In an interesting historical twist, Converde Energy USA, Inc. (OTC: XFUL), d/b/a American Energy Partners, Inc., and its subsidiaries are providing solutions in the same area where some the country’s first oil wells were drilled. The company’s sweet spot is where energy production and water meet technology. XFUL’s subsidiaries target energy operations to design, build and operate regional water treatment facilities that serve both the industrial and energy sectors. Together, American Energy Partners and its subsidiaries comprise an integrated vertical that sources, scrubs, and supplies water to mining, oil and gas, power, and other industrial concerns.

The company’s Hydration Corporation of PA (HCPA) subsidiary possesses the technical know-how to source, implement and distribute reclaimed water at a profit. HCPA’s patent-pending process delivers among the highest energy yields possible from a wide range of water-bearing assets and does so with one of the lowest capital expenditures of any other known water process.

XFUL’s American Energy Solutions subsidiary provides off-the-shelf and custom-designed treatment technologies across its customer base and augments HCPA’s low-cost treatment and distribution solutions, while the company’s Gilbert Oil & Gas Company subsidiary is its oil and gas business arm that leverages relationships and experience to source drilling, operating, and partnership opportunities in the oil and gas space. Gilbert Oil & Gas is positioned to not only become a strong customer of the other subsidiaries but also to attract other customers and open new markets.

With almost 90% of all new U.S. onshore oil and gas hydraulically fractured, demand for XFUL’s integrated oil and water services could surge. Who says oil and water don’t mix?

For more information, visit the company’s website at www.AmericanEnergy-Inc.com

Let us hear your thoughts: Converde Energy USA, Inc. Message Board

• Patented lipophilic delivery system increases bio-absorption
• Patents cover broad range of lipophilic bio-actives, including cannabinoids, vitamins, other pharma
• 19 patents filed across 44 countries
• First international patent issued and approved in Australia

Any argument over the efficacy of medicinal marijuana is settled science. Recent prestigious clinical studies have provided conclusive evidence that medical cannabinoids are effective medicine for a variety of diseases and ailments (http://dtn.fm/C9Sao). However, the human gastrointestinal tract just doesn’t absorb cannabinoids effectively, and much of what is ingested is simply excreted by the body. Subsequently, onset times and effectiveness vary wildly.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has patented and licenses a novel delivery system which infuses organically sourced hemp oil into the molecules of other substances. The system utilizes lipids, which form the basis of the human endocannabinoid system, increasing both absorption and bioavailability of payload molecules. Lexaria’s lipophilic enhancement technology increases the bio-absorption of cannabinoid edibles by five to 10 times, to roughly equal that of inhalation. The onset times for effectiveness are also reduced by about 75 percent due to rapid bio-absorption by bypassing first-pass liver metabolism. Not only does Lexaria’s methodology dramatically increase effectiveness; it also masks the taste of cannabinoids and eliminates the need for sugar additives.

Lexaria currently has 19 patent applications filed in the U.S. and internationally covering 44 countries. The patents encompass a broad range of lipophilic bio-actives including NSAIDs and Nicotine, as well as food/carrier that can be formulated and delivered using Lexaria’s technology. With U.S. patents already issued, the company announced just last week that its first international patent was accepted and issued in Australia (http://dtn.fm/zjN9O). This development opens the door for Lexaria to bring the Australian cannabinoid edibles market under its umbrella.

Chris Bunka, CEO of Lexaria, stated in the news release. “We are very pleased to have received this patent which effectively covers all cannabis oil extract formulated edibles utilizing our technology in Australia…(the) patent award allows us to confidently enter the recently legalized Australian cannabis marketplace where we will seek additional licensing and product distribution partnering opportunities.”

Lexaria employs a low-cost, high-margin license and royalty model of revenue generation. By out-licensing to third party partners, the company keeps five to 10 percent of each partner’s gross sales. With multiple royalty agreements already in the works, the company will continue to expand its licensing network as it receives patent approvals. Interestingly, Lexaria’s novel technology has implications across a wide swath of consumer and pharmaceutical delivery protocols. The global impact of Lexaria’s patents and business model will easily reverberate to the bottom line and has only just begun.

For more information, visit the company’s website at www.LexariaEnergy.com

Let us hear your thoughts: Lexaria Bioscience Corp. Message Board

• Company sees four to five more acquisitions in pipeline after its investment in California firms DIGS and Convectium
• Hired a blockchain expert as part of project addressing payment processes for the cannabis industry
• Hired Turner, Stone & Company LLC to complete 2016 financial audit

Wil Ralston, president of SinglePoint, Inc., (OTC: SING), and Greg Lambrecht, CEO, say their company is primed to make four to five more acquisitions as it sees further opportunity in the cannabis market and medical marijuana. It is supporting dispensaries with the cryptocurrency bitcoin and is helping legal sellers solidify an online presence with subsidiary SingleSeed.com. SinglePoint has hired a digital technology blockchain expert and will launch a project to determine a solution for payment processes within the cannabis industry.

The company’s recent online audio press release (http://dtn.fm/4lNeO) illustrates how this Seattle-based full service mobile technology provider is transitioning into a diversified holding company. It is committed to growing in the cannabis industry. It has formed a joint venture with First Bitcoin Capital Corp. (http://dtn.fm/xNi0e) to offer a payments solution using blockchain technology. The goal is to develop a proprietary solution for high-risk vertical businesses within the cannabis industry. Vancouver, Canada-based First Bitcoin Capital (OTC: BITCF) is a vertically-integrated, publicly traded bitcoin entity.

In May 2017, SinglePoint acquired 90% of discount indoor garden supply firm DIGS. That purchase put SinglePoint further into the online marketplace. That company has two brick-and-mortar store locations in California and is eyeing a third. It also has an online store, www.DIGSHydro.com. SinglePoint has also acquired a portion of Convectium (http://dtn.fm/9Bk7M). This California company creates infrastructure for firms in the cannabis market. It has developed a unique oil filling system, and its products will be sold through SinglePoint’s SingleSeed.com subsidiary.

CEO Lambrecht said SinglePoint is focused on organic growth and acquisition. He is optimistic about legislation coming from the new administration and, eventually, banks opening up to the cannabis industry. “Singlepoint is basically a mobile payments technology company, but we’re able to really jump into any vertical because almost every business has a payment option,” Lambrecht said in the release.

Lambrecht, also president, CEO and founder of SingleSeed, added that SingleSeed.com can enable cannabis retailers to process sales using bitcoin and help dispensaries use online marketing strategies such as texting and mobile phone sales. He explains how the company’s cashless ATMs on site can offer dispensaries the ease of accepting a cashless transaction with bitcoin for a cannabis or medical marijuana purchase. Revenue streams for SinglePoint are created through a transaction commission.

SinglePoint is positioned to benefit from the growth of the cannabis industry. Additionally, Lambrecht disclosed that Turner, Stone & Company, LLP, has been hired to complete an audit of SinglePoint’s financials for 2016.

For a detailed executive audio interview on the announcement, see http://dtn.fm/Rn6wb, or visit www.SinglePoint.com for additional information on the company.

Let us hear your thoughts: SinglePoint, Inc. Message Board

• China’s economy is the world’s second-largest
• Former chairman of Morgan Stanley Asia says China is on the cusp of an incredible growth spurt
• Moxian contributes to and reaps rewards from China’s growth

China, the world’s second-largest economy, is on the cusp of an incredible growth spurt, says Stephen Roach, the former chairman of Morgan Stanley Asia (http://dtn.fm/Y5iCU). In a recent CNBC interview, Roach stated, “The Chinese economy seems to be making remarkable progress in transforming itself into more of a consumer-based model… The wave of innovation in their private-based economy, anything from e-commerce to medical sciences, is really quite spectacular… [China’s] e-commerce share of total consumption is more than double ours [U.S.], and that gap is rising.”

Helping trigger this spectacular transformation and bridging e-commerce to brick and mortar retail is Moxian, Inc. (NASDAQ: MOXC). Moxian’s creative and socially interactive online platforms and mobile applications are moving the burgeoning Chinese consumer from online views to retail purchases at Moxian’s brick and mortar client locations. Moxian’s seductive social network integrates social media and business into a single platform that offers products, features and services that appeal to consumers, keeps them engaged and refers new customers.

The company’s ingenious and captivating online platforms and mobile applications, the Moxian+ User app and the Moxian+ Business app, allow businesses to interface with both new and existing customers. These online interactions provide each business the data to analyze consumer likes, dislikes and trends. Moxian’s platforms offer businesses the ability to create, manage and promote individualized customer loyalty programs, targeted advertising campaigns and special promotions. These interactions between users and Moxian’s merchant clients drive retail traffic into the brick and mortar locations and gives merchant clients the ability to study consumer behavior and custom tailor offerings to consumers.

Impressive by almost any standard, China’s GDP growth has hovered around seven percent the last several years. However, if, as the former chairman of Morgan Stanley Asia predicts, a consumer driven “spectacular transformation” is under way in the Chinese economy, then China could easily see ten, 12, even 14 percent GDP growth as it did early this century. With the remarkable niche it has carved out, Moxian will no doubt contribute to and reap the rewards from this spectacular transformation.

For more information, visit the company’s website at www.Moxian.com

• Connecting a global financial market to a private banking network
• A cloud-based financial platform for trading & settlement of depositary accounts
• Using blockchain technology to deliver secure financial transactions

Banking has come a long way from the time when moneychangers set up their tables in the marketplace. The technology then was minimal: paper records of bills of exchange and letters of credit. Today, technology dominates banking. More than a quarter (about 9,000) of Goldman Sachs’ 33,000 full-time employees are engineers and programmers, by one account (http://dtn.fm/dX51Z). Its CEO is on record as saying that Goldman Sachs (NYSE: GS) is a technology firm, a pointed indication of the extent to which information technologies have permeated modern banking. To serve this growing fintech market, California-based Global Payout, Inc. (OTC: GOHE) is rapidly developing a variety of innovative products. The company is offering state-of-the-art software solutions to fintech companies involved in processing money remittances, wire transfers, bill payments, business-to-business (B2B) payments, currency exchange, eWallet payments and other types of financial transactions.

Since its inception in 2009, Global Payout, Inc. has been a leading provider of comprehensive and customized prepaid payment solutions for domestic and international organizations distributing money worldwide. The company was founded by Jim Hancock, who has guided its evolution from a program management and consulting services company offering prepaid debit cards and electronic wallet products to the global, full-service payment platform it is today. Hancock is Global Payout’s current CEO and chairman. His 30 years of experience range over a variety of industries and include senior positions in investment banking, mergers and acquisitions, payment processing and telecommunications. For the last 14 years, he has successfully managed close to 40 custom-designed prepaid debit card programs. Hancock intends to leverage his vast array of contacts and in-depth knowledge of the payment industry in executing Global Payout’s new initiatives.

These began in 2014, when the company introduced its first online payment platform, called the Consolidated Payment Gateway (CPG). CPG allows its enterprise clients the capability to transfer money to international bank accounts, mobile accounts, and prepaid card accounts. The development of the CPG became the foundation for the introduction of the company’s present, state-of-the-art fintech payment system in 2016, which both expands the range of financial services available to clients and offers them reduced transaction costs.

In January 2017, Global Payout announced a licensing agreement with First American Electronic Payment Solutions, Inc., producer of an innovative software system for companies wishing to process money remittances, wire transfers, bill payments, B2B transactions, eWallet payments and transfers, currency exchanges and other types of financial transactions. This collaboration provides the backbone infrastructure that supports the company’s recently introduced Global Reserve Platform (GRP), a customizable, “banking-in-a-box” web-based platform. GRP offers the capability to execute the front-to-back office processing requirements of domestic/foreign exchange and international payment service providers and is expected to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

Global Payout is connecting this worldwide cloud-based financial services platform to traditional banking. The company holds majority control of ISBC Holdings, Ltd., the sole domestic and international management company for the International Sovereign Banking Corporation (ISBC). ISBC is a privately-owned sovereign nation bank to be held on the sovereign tribal land of the Wakpamni Lake Community, Oglala Sioux Tribe located at the Pine Ridge Tribal Reservation in South Dakota.

With such a spectrum of services, Global Payout can offer traditional banking and products to businesses that cannot access those services. For example, last year, the company announced that Marijuana Company of America (OTC: MCOA) had selected Global Payout as its financial solutions provider (http://dtn.fm/bM1ZE). Global Payout’s CPG and MoneyTrac prepaid solutions will enable MCOA to process membership fees and pay vendors, employees, and affiliates. MCOA members will be able to make purchases using an MCOA-branded prepaid card, reducing cash transactions and enabling online and mobile purchases. This significantly reduces the risk associated with operating a cash-only cannabis business and the legal perils associated with the substance.

For more information, visit the company’s website at www.GlobalPayout.com

• India has world’s second-largest population at 1.35 billion
• India is largest under-banked population in the world
• MoneyOnMobile services under-banked with digital mobile payment network
• 39 percent monthly compounded revenue growth in Q1

With an average growth rate of around seven percent over the last two decades, India’s economy is the sixth-largest in the world measured by GDP and the third-largest by purchasing power. In spite of its economic prowess, the Indian consumer market is the largest under-banked population in the world. Banking services are scarce and woefully inadequate, forcing cash transactions and chocking consumer purchasing power. A prime example of scarce banking services is India’s paltry 200,000 ATMs servicing its 1.35 billion citizens. India would need two million more ATMs in order to have the same ratio of ATMs to people as in the U.S.

Since 2010, MoneyOnMobile, Inc. (OTCQX: MOMT) has been delivering needed services to India’s vast un-banked and under-banked population. MoneyOnMobile is a digital mobile phone payment network that allows consumers to deposit cash with one of its 335,000 retailers in 700+ cities. MoneyOnMobile is authorized by the Reserve Bank of India (RBI) to set up this semi-closed payment network, which enables registered users to buy goods, products and services from registered merchants.

The consumers’ cash deposits become digital currency in MoneyOnMobile’s computerized records. Consumers then have the ability to perform over 55 different transactions, including various bill payments, cash withdrawal, domestic remittances and money transfer using only their mobile phone and SMS text messaging. The system is faster, safer, more reliable, cheaper and much easier to use than transacting in all cash.

MoneyOnMobile is being embraced by the Indian un-banked and under-banked consumer, and the company’s reach into the remotest parts of India makes it the go-to prepaid instrument on the market today. The company has already served over 198 million cumulative unique mobile phone number users and has processed $1.8 billion worth of transactions. Convinced it’s just getting traction, MoneyOnMobile had 39 percent monthly compounded revenue growth in the three months from January to May 2017.

MoneyOnMobile’s cellular prepaid digital payment system is directly centered in one of highest spheres of growth in the financial services arena. The company’s no-cost to end-user services meet a vast unmet need in one of the world’s most populated countries, providing users newfound flexibility and self-dependence. It shouldn’t be long before MoneyOnMobile’s growth numbers eclipse the first three months of this year.

For more information, visit the company’s website at www.Investors.MoneyOnMobile.in

• Proven player in the payments-as-a-service market
• Company’s business growth increased by 40% in 2017’s first quarter
• Projected to reach $75 million in revenues by 2018

Exciting developments continue for Net Element, Inc. (NASDAQ: NETE), which has become a proven entity within the thriving payments-as-a-service market.

Net Element is a global financial technology and value-added solutions group engaged in supporting electronic payments acceptance in an omni-channel environment that spans point-of-sale, e-commerce and mobile devices. The company’s payments-as-a-service transactional and value-added services platform caters to small-to-medium enterprises (SME) in the United States and in selected emerging markets. Net Element was hailed as one of the fastest-growing technology companies by the South Florida Business Journal in 2016, and the company continues living up to that title.

On July 20, Net Element announced that its PayOnline subsidiary has expanded its payments module for electronic commerce and CMS to now include InSales, a popular omni-channel commerce and CMS platform for small-to-medium-sized businesses (http://dtn.fm/t7J3Y). The free PayOnline module for InSales enables merchants to accept payments via the most popular bankcards, such as Visa, Visa Electron, MasterCard, Maestro and MIR. Additionally, the PayOnline module supports more than 110 key world currencies, including U.S. dollars, euros, rubles, tenge, soms and shekels. All of the PayOnline module’s payment interfaces are available in English and Russian, and PayOnline has gained access to more than 4,000 new merchants in Russia and Kazakhstan with this latest addition, which means significant revenue potential for Net Element. The payment module is available on 23 of the most popular e-commerce and CMS platforms and counting.

In June, Net Element announced, through its PayOnline subsidiary, that its list of European integrations and partnerships had expanded via the addition of Payvision to the company’s network of partners. This provided PayOnline with an additional channel through which to route its payments in Europe and effectively broadened the scope of capabilities for its customers, simultaneously supporting higher conversion rates and improving access to more than 120 currencies throughout the world.

Also in June came the announcement that Net Element’s PayOnline subsidiary had initiated payment acceptance services for V-Tell, a premier international mobile network operator. V-Tell’s intention was to use various payment methods offered through the PayOnline platform for its website and mobile application, including recurring billing and one-click payment solutions.

Net Element’s business growth was up an impressive 40 percent in the first quarter of 2017, and a Zacks Research Report released in May (http://dtn.fm/fI97p) projected that the company’s revenues will reach $75 million by 2018.

Continuing its impressive growth trajectory, Net Element is successfully demonstrating its ability to grow internationally and is poised for even greater success in the near term.

For more information, visit the company’s website at www.NetElement.com

• Specializing in novel cannabinoid drug therapies, InMed Pharmaceuticals is well-poised for cannabinoid research and development of new treatments
• Glaucoma and skin disease pharmaceuticals now in development have an estimated $7.6 billion potential market
• InMed Pharmaceutical’s chief medical officer helped $3 billion GW Pharmaceuticals develop one of the first cannabis-based drugs

With its proprietary bioinformatics assessment tool, cannabinoid biosynthesis technology and drug development pipeline, InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is well-positioned to target the future of cannabinoid pharmaceutical compounds.

InMed is a pre-clinical stage biopharmaceutical company specializing in the development of novel therapies through research and development of the 90+ individual cannabinoid compounds which occur naturally in cannabis.

InMed can rapidly analyze and identify novel cannabinoids to find new drug candidates with the highest therapeutic benefit and fewest adverse effects. The company’s unique research approach using proprietary bioinformatics tools expedites the identification of bioactive compounds with the potential to treat specific diseases, while its comprehensive pharmaceutical and cannabinoid structures database allow InMed to identify active cannabinoids that will act on genes and proteins.

Two major medications are in development by InMed Pharmaceuticals: a glaucoma treatment and a drug therapy for epidermolysis bullosa (EB). The two markets combined have an estimated value of $7.6 billion. Clinical trials for both candidates are expected to start in 2018.

In June, InMed Pharmaceuticals announced an agreement with Pharmaseed Ltd. to develop the final formulation for INM-750, a treatment in development as a therapy for EB and other dermatological and wound applications.

Epidermolysis bullosa comprises a group of inherited connective tissue diseases which typically affect the skin, causing it to become extremely fragile and prone to blistering and tearing. The disease can also affect bodily systems and internal organs. There is currently no approved treatment for EB. InMed’s topical formulation includes multiple cannabinoids to target keratin modulation, as well as inflammation, healing, skin regeneration, itching, and pain.

A second pharmaceutical in InMed’s pipeline, INM-085, treats glaucoma, an eye disorder which increases pressure in the eye, damages the optic nerve and is one of the leading causes of blindness in the developed world. The glaucoma medication could become the first-ever treatment for the disease that is multi-target and uses multiple cannabinoids for maximum effectiveness.

InMed Pharmaceuticals’ impressive management team includes Chief Medical Officer Dr. Ado Muhammed, a former associate medical director for GW Pharmaceuticals. Muhammed was instrumental in leading GW Pharmaceuticals (NASDAQ: GWPH) through development and approval of one of the world’s first cannabis-based drugs, taking the company’s shares from less than $9 in 2013 to $100 today and building a market value of more than $2.5 billion.

InMed Pharmaceuticals president and CEO Eric Adams is a seasoned biopharmaceutical executive with over 25 years’ experience in company and capital formation, global market development, mergers & acquisitions, licensing and corporate governance. Adams previously served as CEO at enGene Inc. and held key senior roles in global market development with QLT Inc. (Vancouver), Advanced Tissues Science Inc. (La Jolla), Abbott Laboratories (Chicago), and Fresenius AG (Germany).

InMed’s Chief Scientific Officer Dr. Sazzad Hossain has more than 20 years of academic and industrial experience in new drug discovery and natural health product development. Hossain held key roles at the Biotechnology Research Institute of National Research Council Canada and Xenon Pharmaceuticals. CFO Jeff Charpentier is a 25-year veteran of the biopharmaceutical industry and has served at several public and private companies in the pharmaceutical and technology sectors.

With lots of opportunity, a share price of less than 30 cents and a market cap of about $34 million, InMed looks like a good opportunity to profit from what may become the next success story in the ongoing quest to cure and mitigate disease with cannabinoid-based therapeutics.

For more information, visit the company’s website at www.InMedPharma.com

Let us hear your thoughts: InMed Pharmaceuticals, Inc. Message Board